DK127676B - Fremgangsmåde til fremstilling af et prothrombinkompleks indeholdende koagulationsfaktorer. - Google Patents
Fremgangsmåde til fremstilling af et prothrombinkompleks indeholdende koagulationsfaktorer.Info
- Publication number
- DK127676B DK127676B DK317070AA DK317070A DK127676B DK 127676 B DK127676 B DK 127676B DK 317070A A DK317070A A DK 317070AA DK 317070 A DK317070 A DK 317070A DK 127676 B DK127676 B DK 127676B
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- complex containing
- coagulation factors
- prothrombin complex
- containing coagulation
- Prior art date
Links
- 108010039209 Blood Coagulation Factors Proteins 0.000 title 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 title 1
- 108010094028 Prothrombin Proteins 0.000 title 1
- 102100027378 Prothrombin Human genes 0.000 title 1
- 239000003114 blood coagulation factor Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229940039716 prothrombin Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
- Y10S530/831—Cohn fractions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83488369A | 1969-06-19 | 1969-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK127676B true DK127676B (da) | 1973-12-17 |
Family
ID=25268043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK317070AA DK127676B (da) | 1969-06-19 | 1970-06-19 | Fremgangsmåde til fremstilling af et prothrombinkompleks indeholdende koagulationsfaktorer. |
Country Status (13)
Country | Link |
---|---|
US (1) | US3560475A (fr) |
BE (1) | BE751667A (fr) |
CA (1) | CA920058A (fr) |
DE (1) | DE2029455C3 (fr) |
DK (1) | DK127676B (fr) |
ES (1) | ES380950A1 (fr) |
FR (1) | FR2052987B1 (fr) |
GB (1) | GB1253339A (fr) |
IL (1) | IL34599A (fr) |
IT (1) | IT1043810B (fr) |
NL (1) | NL170150C (fr) |
SE (1) | SE397474B (fr) |
ZA (1) | ZA703574B (fr) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3803115A (en) * | 1972-05-17 | 1974-04-09 | Baxter Laboratories Inc | Stabilization of ahf using heparin |
US3956259A (en) * | 1973-01-30 | 1976-05-11 | Baxter Laboratories, Inc. | Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate |
US4073886A (en) * | 1973-01-30 | 1978-02-14 | Baxter Travenol Laboratories, Inc. | Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene |
US4025500A (en) * | 1974-06-06 | 1977-05-24 | Baxter Laboratories, Inc. | Preparation of albumin by fractionation of blood plasma or serum |
US4001401A (en) * | 1975-02-02 | 1977-01-04 | Alza Corporation | Blood substitute and blood plasma expander comprising polyhemoglobin |
US4046877A (en) * | 1975-07-18 | 1977-09-06 | Syntex (U.S.A.) Inc. | Method of increasing immunologic competence |
DE2902158A1 (de) * | 1979-01-20 | 1980-07-31 | Biotest Serum Institut Gmbh | Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen |
FR2472390A1 (fr) * | 1979-05-04 | 1981-07-03 | Merieux Inst | Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus |
US4286056A (en) * | 1980-01-28 | 1981-08-25 | Baxter Travenol Laboratories, Inc. | Method for making therapeutic enzyme compositions |
WO1981002105A1 (fr) * | 1980-01-28 | 1981-08-06 | Baxter Travenol Lab | Compositions therapeutiques et procede de fabrication et d'utilisation de celles-ci |
US4287180A (en) * | 1980-01-28 | 1981-09-01 | Baxter Travenol Laboratories, Inc. | Method for treating blood clotting factor inhibitors |
US4404132A (en) * | 1980-05-27 | 1983-09-13 | Cutter Laboratories, Inc. | Blood coagulation promoting product |
US4361510A (en) * | 1980-05-27 | 1982-11-30 | Cutter Laboratories, Inc. | Blood coagulation promoting product |
US4391746A (en) * | 1980-05-27 | 1983-07-05 | Cutter Laboratories, Inc. | Blood-coagulation-promoting products and methods of preparing them |
US4364861A (en) * | 1980-05-27 | 1982-12-21 | Cutter Laboratories, Inc. | Blood-coagulation-promoting products and methods of preparing them |
US4382083A (en) * | 1981-06-25 | 1983-05-03 | Baxter Travenol Laboratories, Inc. | Therapeutic method for treating blood-clotting defects with factor VIIa |
US4479938A (en) * | 1981-06-25 | 1984-10-30 | Baxter Travenol Laboratories, Inc. | Therapeutic composition containing factor VIIa |
US5055557A (en) * | 1983-03-04 | 1991-10-08 | Scripps Clinic & Research Foundation | Ultrapurification of factor IX and other vitamin K-dependent proteins |
US5614500A (en) * | 1983-03-04 | 1997-03-25 | The Scripps Research Institute | Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography |
US4786726A (en) * | 1986-01-06 | 1988-11-22 | Blood Systems, Inc. | Factor IX therapeutic blood product, means and methods of preparing same |
ZA877535B (en) * | 1986-10-09 | 1988-04-11 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | Factor ix-peptides |
USH1509H (en) * | 1989-06-09 | 1995-12-05 | Eran; Harutyun | Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate |
US5659017A (en) * | 1995-11-07 | 1997-08-19 | Alpha Therapeutic Corporation | Anion exchange process for the purification of Factor VIII |
USRE38431E1 (en) * | 1995-12-01 | 2004-02-17 | The American National Red Cross | Methods of production and use of liquid formulations of plasma proteins |
US6320029B1 (en) | 1996-11-29 | 2001-11-20 | The American National Red Cross | Methods of production and use of liquid formulations of plasma proteins |
US5925738A (en) * | 1995-12-01 | 1999-07-20 | The American National Red Cross | Methods of production and use of liquid formulations of plasma proteins |
JP3944267B2 (ja) * | 1996-08-09 | 2007-07-11 | 財団法人化学及血清療法研究所 | プロトロンビンの活性化方法および該方法に基づくトロンビンの製造方法 |
US5770705A (en) * | 1996-11-01 | 1998-06-23 | Shanbrom Technologies Llc | Method for recovering proteins from plasma using insoluble, water-absorbing material |
US7297716B2 (en) * | 2000-10-23 | 2007-11-20 | Shanbrom Technologies, Llc | Enhanced production of blood components, blood cells and plasma without freezing |
US7411006B2 (en) * | 2000-10-23 | 2008-08-12 | Shanbrom Technologies, Llc | Enhanced production of blood clotting factors and fibrin fabric |
US8389687B2 (en) * | 2000-10-23 | 2013-03-05 | Shanbrom Technologies, Llc | Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors |
WO2005094873A1 (fr) | 2004-03-19 | 2005-10-13 | Baxter International Inc. | Facteur ixa pour le traitement de troubles de saignement |
WO2022064478A1 (fr) | 2020-09-23 | 2022-03-31 | Omrix Biopharmaceuticals Ltd. | Formulations hémostatiques et leurs utilisations |
-
1969
- 1969-06-19 US US834883A patent/US3560475A/en not_active Expired - Lifetime
- 1969-12-29 CA CA070973A patent/CA920058A/en not_active Expired
-
1970
- 1970-05-26 ZA ZA703574A patent/ZA703574B/xx unknown
- 1970-05-26 IL IL34599A patent/IL34599A/en unknown
- 1970-05-28 GB GB25674/70A patent/GB1253339A/en not_active Expired
- 1970-06-09 BE BE751667D patent/BE751667A/fr not_active IP Right Cessation
- 1970-06-15 DE DE2029455A patent/DE2029455C3/de not_active Expired
- 1970-06-17 SE SE7008429A patent/SE397474B/xx unknown
- 1970-06-18 IT IT26213/70A patent/IT1043810B/it active
- 1970-06-18 NL NLAANVRAGE7008957,A patent/NL170150C/xx not_active IP Right Cessation
- 1970-06-18 FR FR7022476A patent/FR2052987B1/fr not_active Expired
- 1970-06-19 DK DK317070AA patent/DK127676B/da unknown
- 1970-06-19 ES ES380950A patent/ES380950A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ES380950A1 (es) | 1972-10-16 |
BE751667A (fr) | 1970-11-16 |
IT1043810B (it) | 1980-02-29 |
NL170150C (nl) | 1982-10-01 |
NL170150B (nl) | 1982-05-03 |
FR2052987B1 (fr) | 1974-05-24 |
SE397474B (sv) | 1977-11-07 |
IL34599A0 (en) | 1970-07-19 |
CA920058A (en) | 1973-01-30 |
NL7008957A (fr) | 1970-12-22 |
US3560475A (en) | 1971-02-02 |
GB1253339A (en) | 1971-11-10 |
DE2029455A1 (de) | 1971-02-25 |
DE2029455C3 (de) | 1979-04-19 |
IL34599A (en) | 1973-07-30 |
DE2029455B2 (de) | 1978-08-24 |
ZA703574B (en) | 1971-01-27 |
FR2052987A1 (fr) | 1971-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK127676B (da) | Fremgangsmåde til fremstilling af et prothrombinkompleks indeholdende koagulationsfaktorer. | |
DK130018B (da) | Fremgangsmåde til fremstilling af L-lysin. | |
DK130306B (da) | Analogifremgangsmåde til fremstilling af S-trialkylphosphinguld-1-thio-β-D-glucopyranosider. | |
DK136314B (da) | Analogifremgangsmåde til fremstilling af benzamidoethylpiperaziner. | |
DK137167B (da) | Fremgangsmåde til fremstilling af et stabilt skumdæmpende middel. | |
DK135760B (da) | Fremgangsmåde til fremstilling af vanadiumforbindelser. | |
DK140697B (da) | Fremgangsmåde til fremstilling af 2-amino-4-hydroxy-6-hydroxymethyl-7,7-dimethyl-7,8-dihydropteridin. | |
DK124195B (da) | Fremgangsmåde til fremstilling af cis-chrysantheminsyrer. | |
DK133375B (da) | Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-phenylpyrrolidiner. | |
DK130576B (da) | Fremgangsmåde til fremstilling af et formgivet katalysatormateriale. | |
DK128006B (da) | Analogifremgangsmåde til fremstilling af 11-desacetoxy-wortmannin. | |
DK122105B (da) | Fremgangsmåde til fremstilling af et prothrombinkompleks indeholdende koagulationsfaktorer. | |
DK128737B (da) | Analogifremgangsmåde til fremstilling af 6α-methyl-17α-caproyloxy-19-norprogesteron. | |
DK125199B (da) | Analogifremgangsmåde til fremstilling af benzamidiner. | |
DK129045B (da) | Analogifremgangsmåde til fremstilling af (p-fluorpheny)-pyridincarboxylsyrer. | |
DK122456B (da) | Fremgangsmåde til fremstilling af quinoxalin-di-N-oxid-aldehyd. | |
DK122127B (da) | Analogifremgangsmåde til fremstilling af 3-phenyl-4-acyloxycarbostyriler. | |
DK123816B (da) | Analogifremgangsmåde til fremstilling af N-phenacylcarbamater. | |
DK124686B (da) | Analogifremgangsmåde til fremstilling af bis-thiachromonylforbindelser. | |
DK139071B (da) | Fremgangsmåde til fremstilling af copolymerisater. | |
DK126660B (da) | Fremgangsmåde til fremstilling af et vanduopløseligt enzympræparat. | |
DK123527B (da) | Fremgangsmåde til fremstilling af lumilysergsyrederivater. | |
DK132026B (da) | Fremgangsmåde til fremstilling af 6-aminoacylamidopenicillansyrer. | |
DK124478B (da) | Fremgangsmåde til fremstilling af triklormetantiosulfenylklorid. | |
DK125918B (da) | Fremgangsmåde til fremstilling af alkyl-7-0-methyl-l-thio-lincosaminider. |